Healthcare Sales & Marketing Network News: Fusarium

Searching News Database: Fusarium

HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Oct 2019
Eyevance Pharmaceuticals Acquires TOBRADEX(R) ST and NATACYN(R)
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 11 Feb 2019
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Mar 2018
Amplyx Pharmaceuticals Receives Fourth "Qualified Infectious Disease Product" (QIDP) Designation from the FDA for APX001
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Aug 2017
Amplyx Pharmaceuticals Raises $67 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 May 2006
CDC Report Supports Bausch & Lomb's Decision to Recall MoistureLoc(R) Solution, Only Product Associated with Unusual Increase in Fusarium Infections
Devices Ophthalmology FDA

HSMN NewsFeed - 17 May 2006
Bausch & Lomb Clarifies Reporting of Fusarium Keratitis Cases to FDA
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 15 May 2006
Bausch & Lomb Voluntarily Recalls MoistureLoc(R) Worldwide
Biopharmaceuticals Ophthalmology Product Recall

Return to NewsFeed

Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 8 additional stories matching:
Fusarium
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!